Recombinant multi-species FKBP3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FKBP3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. This encoded protein is a cis-trans prolyl isomerase that binds the immunosuppressants FK506 and rapamycin, as well as histone deacetylases, the transcription factor YY1, casein kinase II, and nucleolin. It has a higher affinity for rapamycin than for FK506 and thus may be an important target molecule for immunosuppression by rapamycin. [provided by RefSeq, Sep 2008]
The Alternative Names of target: 25 kDa FK506-binding protein (25 kDa FKBP,25kDa,FK506-binding protein 3 (FKBP-3),FKBP-25,FKBP-25),FKBP-3,FKBP25,FKBP3,Fkbp3,Immunophilin FKBP25,PPIase,PPIase FKBP3,Peptidyl-prolyl cis-trans isomerase FKBP3,Rapamycin-selective 25 kDa immunophilin,Rotamase

Target products collectionGo to FKBP3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6604-Ag-1/ GM-Tg-hg-IP6604-Ag-2 Human FKBP3 protein Human
GM-Tg-rg-IP6604-Ag-1/ GM-Tg-rg-IP6604-Ag-2 Rat FKBP3 protein Rat
GM-Tg-mg-IP6604-Ag-1/ GM-Tg-mg-IP6604-Ag-2 Mouse FKBP3 protein Mouse
GM-Tg-cynog-IP6604-Ag-1/ GM-Tg-cynog-IP6604-Ag-2 Cynomolgus/Rhesus macaque FKBP3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6604-Ag-1/ GM-Tg-felg-IP6604-Ag-2 Feline FKBP3 protein Feline
GM-Tg-cang-IP6604-Ag-1/ GM-Tg-cang-IP6604-Ag-2 Canine FKBP3 protein Canine
GM-Tg-bovg-IP6604-Ag-1/ GM-Tg-bovg-IP6604-Ag-2 Bovine FKBP3 protein Bovine
GM-Tg-equg-IP6604-Ag-1/ GM-Tg-equg-IP6604-Ag-2 Equine FKBP3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6604-Ag-1/ GM-Tg-hg-IP6604-Ag-2; GM-Tg-rg-IP6604-Ag-1/ GM-Tg-rg-IP6604-Ag-2;
GM-Tg-mg-IP6604-Ag-1/ GM-Tg-mg-IP6604-Ag-2; GM-Tg-cynog-IP6604-Ag-1/ GM-Tg-cynog-IP6604-Ag-2;
GM-Tg-felg-IP6604-Ag-1/ GM-Tg-felg-IP6604-Ag-2; GM-Tg-cang-IP6604-Ag-1/ GM-Tg-cang-IP6604-Ag-2;
GM-Tg-bovg-IP6604-Ag-1/ GM-Tg-bovg-IP6604-Ag-2; GM-Tg-equg-IP6604-Ag-1/ GM-Tg-equg-IP6604-Ag-2
Products Name FKBP3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FKBP3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FKBP3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.